CSDL Bài trích Báo - Tạp chí
chủ đề: Pneumonia--Viêm phổi
1 Management of pneumonitis post-concurrent chemoradiation and immunotherapy in patients with advanced lung cancer: Case report and litterature review / Nguyen Van Hung, Nguyen Nhat Tan, Pham Duy Manh, Tran Trung Bach, Trinh Le Huy // .- 2024 .- Volume 184 E15 - N 11 .- P. 188-193 .- 610
Immune-related pneumonitis is a rare but serious complication in patients with non-small cell lung cancer (NSCLC) treated with durvalumab after concurrent chemoradiotherapy (CRT). We encountered a 61-year-old male with stage III non-small cell lung cancer (NSCLC) receiving concurrent chemoradiotherapy followed by durvalumab maintenance therapy. After 1 cycle of durvalumab treatment, he developed progressive dyspnea, dry cough, and low-grade fever. Chest CT scans revealed diffuse ground-glass opacities in both lungs, indicative of immune-related pneumonitis. Durvalumab was discontinued, and the patient was treated with high-dose corticosteroids and antibiotics. After one month, he fully recovered. Durvalumab was cautiously resumed under close monitoring without recurrence of pneumonitis. Conclusion: Early identification and management of immune-related pneumonitis are essential in NSCLC patients receiving durvalumab. Reintroducing durvalumab after recovery may be safe with vigilant monitoring.
2 Clinical, subclinical characteristics and treatment outcomes of patients with community - acquired pneumonia at risk of pes infection / Dang Duy Thanh, Cao Thi My Thuy, Nguyen Thi Hong Tran, Truong Thi Nhu Hao, Vo Nhat Khoa, Nguyen Vu Hien, Nguyen The Bao // .- 2024 .- Volume 177 E14 - N 04 - May .- P. 48-56 .- 610
This study aims to describe the clinical and subclinical characteristics and evaluate treatment outcomes of community-acquired pneumonia (CAP) patients at risk of Pseudomonas aeruginosa, extended-spectrum beta-lactamases-producing Enterobacteriaceae, methicillin-resistant Staphylococcus aureus (PES) infection. A cross-sectional descriptive study was conducted on 90 CAP patients with potential PES infection admitted to the Respiratory Department of Can Tho Central General Hospital in 2023.
3 Clinical outcomes and risk factors for mortality in diabetic patients with staphylococcus aureus pneumonia: A case-control study / Vo Pham Minh Thu, Nguyen Thuy Quyen, Tran Cong Dang, Nguyen The Bao // .- 2024 .- Volume 177 E14 - N 04 - May .- P. 196-203 .- 610
The study was conducted to investigate the clinical outcomes and mortality risk factors related to Staphylococcus aureus pneumonia in patients with and without diabetes mellitus (DM). This was a case-control study on 118 patients with S. aureus pneumonia hospitalized between April 2021 and May 2023.